Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation

Background— Abnormal Ca2+ handling may contribute to impaired atrial contractility and arrhythmogenesis in human chronic atrial fibrillation (cAF). Here, we assessed the phosphorylation levels of key proteins involved in altered Ca2+ handling and contractility in cAF patients. Methods and Results— Total and phosphorylation levels of Ca2+-handling and myofilament proteins were analyzed by Western blotting in right atrial appendages of 49 patients in sinus rhythm and 52 cAF patients. We found a higher total activity of type 1 (PP1) and type 2A phosphatases in cAF, which was associated with inhomogeneous changes of protein phosphorylation in the cellular compartments, ie, lower protein kinase A (PKA) phosphorylation of myosin binding protein-C (Ser-282 site) at the thick myofilaments but preserved PKA phosphorylation of troponin I at the thin myofilaments and enhanced PKA (Ser-16 site) and Ca2+-calmodulin protein kinase (Thr-17 site) phosphorylation of phospholamban. PP1 activity at sarcoplasmic reticulum is controlled by inhibitor-1 (I-1), which blocks PP1 in its PKA-phosphorylated form only. In cAF, the ratio of Thr-35–phosphorylated to total I-1 was 10-fold higher, which suggests that the enhanced phosphorylation of phospholamban may result from a stronger PP1 inhibition by PKA-hyperphosphorylated (activated) I-1. Conclusions— Altered Ca2+ handling in cAF is associated with impaired phosphorylation of myosin binding protein-C, which may contribute to the contractile dysfunction after cardioversion. The hyperphosphorylation of phospholamban probably results from enhanced inhibition of sarcoplasmic PP1 by hyperphosphorylated I-1 and may reinforce the leakiness of ryanodine channels in cAF. Restoration of sarcoplasmic reticulum–associated PP1 function may represent a new therapeutic option for treatment of atrial fibrillation.

[1]  M. Boutjdir,et al.  Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases. , 1999, Circulation research.

[2]  P. Karczewski,et al.  Regulation of the transient outward K(+) current by Ca(2+)/calmodulin-dependent protein kinases II in human atrial myocytes. , 1999, Circulation research.

[3]  M. Allessie,et al.  Troponin I Isoform Expression in Human and Experimental Atrial Fibrillation , 2004, Circulation.

[4]  E. Lakatta,et al.  High Basal Protein Kinase A–Dependent Phosphorylation Drives Rhythmic Internal Ca2+ Store Oscillations and Spontaneous Beating of Cardiac Pacemaker Cells , 2006, Circulation research.

[5]  E. Theodorsson,et al.  Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation. , 1990, British heart journal.

[6]  P. Greengard,et al.  Phosphorylation of Protein Phosphatase Inhibitor-1 by Cdk5* , 2001, The Journal of Biological Chemistry.

[7]  S. Nattel.  New ideas about atrial fibrillation 50 years on , 2002, Nature.

[8]  S. Kano,et al.  Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. , 2006, The Journal of clinical investigation.

[9]  F. Müller,et al.  Protein phosphatase activity is increased in a rat model of long-term β-adrenergic stimulation , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  H. Brasch,et al.  Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. , 1993, Hypertension.

[11]  D. V. Van Wagoner,et al.  Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation , 2001, Circulation.

[12]  Ajay M Shah,et al.  Regulation of cardiac contractile function by troponin I phosphorylation. , 2005, Cardiovascular research.

[13]  H. T. ter Keurs,et al.  Arrhythmogenic Ca(2+) release from cardiac myofilaments. , 2006, Progress in biophysics and molecular biology.

[14]  D. Bers.  Cardiac excitation–contraction coupling , 2002, Nature.

[15]  S. Reiken,et al.  Phosphodiesterase 4D Deficiency in the Ryanodine-Receptor Complex Promotes Heart Failure and Arrhythmias , 2005, Cell.

[16]  Andrew N. Carr,et al.  Type 1 Phosphatase, a Negative Regulator of Cardiac Function , 2002, Molecular and Cellular Biology.

[17]  K. Hamano,et al.  Down‐regulation of sarcolipin mRNA expression in chronic atrial fibrillation , 2004, European journal of clinical investigation.

[18]  Heping Cheng,et al.  Frequency-encoding Thr17 Phospholamban Phosphorylation Is Independent of Ser16 Phosphorylation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[19]  D. Dobrev,et al.  Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation , 2004, Circulation.

[20]  S. Hatem,et al.  Contribution of Na+/Ca2+ exchange to action potential of human atrial myocytes. , 1996, The American journal of physiology.

[21]  Nolwenn Le Meur,et al.  Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation , 2005, Circulation.

[22]  J. Neumann,et al.  Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. , 2000, Physiological reviews.

[23]  J. Stock,et al.  Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits , 2000, The EMBO journal.

[24]  I. V. Van Gelder,et al.  Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. , 1999, Cardiovascular research.

[25]  E. Kranias,et al.  The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. , 1992, Archives of biochemistry and biophysics.

[26]  Andrew N. Carr,et al.  Enhancement of Cardiac Function and Suppression of Heart Failure Progression By Inhibition of Protein Phosphatase 1 , 2005, Circulation research.

[27]  D. Dobrev,et al.  Role of I Kur in Controlling Action Potential Shape and Contractility in the Human Atrium Influence of Chronic Atrial Fibrillation , 2004 .

[28]  Ulrich Gergs,et al.  Overexpression of the Catalytic Subunit of Protein Phosphatase 2A Impairs Cardiac Function* , 2004, Journal of Biological Chemistry.

[29]  T. Hewett,et al.  PKC-α regulates cardiac contractility and propensity toward heart failure , 2004, Nature Medicine.

[30]  S. Huang,et al.  Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. , 1999, Journal of the American College of Cardiology.

[31]  S. Harding,et al.  Evidence for protein phosphatase inhibitor‐1 playing an amplifier role in β‐adrenergic signaling in cardiac myocytes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Allessie,et al.  Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. , 2002, Cardiovascular research.

[33]  E. Olson,et al.  Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A , 2001, Circulation research.

[34]  Stefan Kääb,et al.  Reprogramming of the Human Atrial Transcriptome in Permanent Atrial Fibrillation: Expression of a Ventricular-Like Genomic Signature , 2005, Circulation research.

[35]  R. Tieleman,et al.  Alterations in Gene Expression of Proteins Involved in the Calcium Handling in Patients with Atrial Fibrillation , 1999, Journal of cardiovascular electrophysiology.

[36]  M. Bollen,et al.  Functional diversity of protein phosphatase-1, a cellular economizer and reset button. , 2004, Physiological reviews.

[37]  Wolfgang A. Linke,et al.  I-Band Titin in Cardiac Muscle Is a Three-Element Molecular Spring and Is Critical for Maintaining Thin Filament Structure , 1999, The Journal of cell biology.

[38]  J. Michel,et al.  Constitutive Cardiac Overexpression of Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPase Delays Myocardial Failure After Myocardial Infarction in Rats at a Cost of Increased Acute Arrhythmias , 2004, Circulation.

[39]  T. Hewett,et al.  PKC-alpha regulates cardiac contractility and propensity toward heart failure. , 2004, Nature medicine.

[40]  H. Sabbah,et al.  Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium. , 2002, Biochemical pharmacology.

[41]  P. Cohen,et al.  Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. , 1991, European journal of biochemistry.

[42]  T. Eschenhagen,et al.  Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. , 2004, Cardiovascular research.

[43]  S. Nattel,et al.  Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. , 2003, Cardiovascular research.

[44]  Stephan E. Lehnart,et al.  Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor , 2004, Circulation research.

[45]  S. Nattel,et al.  Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation. , 1999, Cardiovascular research.

[46]  U Schotten,et al.  Cellular Mechanisms of Depressed Atrial Contractility in Patients With Chronic Atrial Fibrillation , 2001, Circulation.

[47]  G. Vassort,et al.  Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. , 2006, Cardiovascular research.

[48]  U Ravens,et al.  L-Type Ca 2 Current Downregulation in Chronic Human Atrial Fibrillation Is Associated With Increased Activity of Protein Phosphatases , 2004 .

[49]  Leif Hove-Madsen,et al.  Atrial Fibrillation Is Associated With Increased Spontaneous Calcium Release From the Sarcoplasmic Reticulum in Human Atrial Myocytes , 2004, Circulation.

[50]  H. Watkins,et al.  Cardiac Myosin Binding Protein C: Its Role in Physiology and Disease , 2004, Circulation research.

[51]  F. Huang,et al.  Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. , 1976, European journal of biochemistry.

[52]  E. Kranias,et al.  Calcium: Phospholamban: a crucial regulator of cardiac contractility , 2003, Nature Reviews Molecular Cell Biology.

[53]  M. Rosen,et al.  Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation , 2005, Circulation.